JPH11507941A - 化学化合物およびその製造方法 - Google Patents
化学化合物およびその製造方法Info
- Publication number
- JPH11507941A JPH11507941A JP9503670A JP50367097A JPH11507941A JP H11507941 A JPH11507941 A JP H11507941A JP 9503670 A JP9503670 A JP 9503670A JP 50367097 A JP50367097 A JP 50367097A JP H11507941 A JPH11507941 A JP H11507941A
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- formula
- skin
- compound
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 100
- 238000004519 manufacturing process Methods 0.000 title claims description 9
- 239000000203 mixture Substances 0.000 claims abstract description 33
- 230000000475 sunscreen effect Effects 0.000 claims abstract description 15
- 239000000516 sunscreening agent Substances 0.000 claims abstract description 15
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 12
- 239000002537 cosmetic Substances 0.000 claims abstract description 11
- 150000003839 salts Chemical class 0.000 claims abstract description 9
- 150000001336 alkenes Chemical class 0.000 claims abstract description 8
- 125000002947 alkylene group Chemical group 0.000 claims abstract description 8
- 239000000654 additive Substances 0.000 claims abstract description 7
- 239000000975 dye Substances 0.000 claims abstract description 6
- 239000003973 paint Substances 0.000 claims abstract description 5
- 230000000996 additive effect Effects 0.000 claims abstract description 4
- 239000000976 ink Substances 0.000 claims abstract description 4
- 125000006615 aromatic heterocyclic group Chemical group 0.000 claims abstract 8
- 238000010521 absorption reaction Methods 0.000 claims description 17
- 239000002253 acid Substances 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 16
- 238000002835 absorbance Methods 0.000 claims description 15
- 150000002148 esters Chemical class 0.000 claims description 14
- 230000008859 change Effects 0.000 claims description 13
- 230000004224 protection Effects 0.000 claims description 9
- 239000002671 adjuvant Substances 0.000 claims description 8
- 238000000862 absorption spectrum Methods 0.000 claims description 6
- 125000000623 heterocyclic group Chemical group 0.000 claims description 5
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 5
- 239000003086 colorant Substances 0.000 claims description 4
- 229920000642 polymer Polymers 0.000 claims description 4
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical class OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 claims description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 3
- 125000005842 heteroatom Chemical group 0.000 claims description 3
- 230000037303 wrinkles Effects 0.000 claims description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 2
- 230000001153 anti-wrinkle effect Effects 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- WBCMGDNFDRNGGZ-ACNVUDSMSA-N coumarate Natural products COC(=O)C1=CO[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H]3[C@@H]1C=C[C@]34OC(=O)C(=C4)[C@H](C)OC(=O)C=Cc5ccc(O)cc5 WBCMGDNFDRNGGZ-ACNVUDSMSA-N 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims description 2
- 125000001931 aliphatic group Chemical group 0.000 claims 1
- 230000032050 esterification Effects 0.000 claims 1
- 238000005886 esterification reaction Methods 0.000 claims 1
- 239000000047 product Substances 0.000 abstract description 15
- 230000003078 antioxidant effect Effects 0.000 abstract description 5
- 125000000524 functional group Chemical group 0.000 abstract description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 24
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 18
- -1 conditioners Substances 0.000 description 15
- 238000002211 ultraviolet spectrum Methods 0.000 description 13
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 239000000463 material Substances 0.000 description 11
- 239000006096 absorbing agent Substances 0.000 description 10
- 230000015572 biosynthetic process Effects 0.000 description 10
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 10
- NGSWKAQJJWESNS-UHFFFAOYSA-N 4-coumaric acid Chemical compound OC(=O)C=CC1=CC=C(O)C=C1 NGSWKAQJJWESNS-UHFFFAOYSA-N 0.000 description 8
- 239000002585 base Substances 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 238000003786 synthesis reaction Methods 0.000 description 7
- AFDXODALSZRGIH-QPJJXVBHSA-N (E)-3-(4-methoxyphenyl)prop-2-enoic acid Chemical compound COC1=CC=C(\C=C\C(O)=O)C=C1 AFDXODALSZRGIH-QPJJXVBHSA-N 0.000 description 6
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 6
- 235000001785 ferulic acid Nutrition 0.000 description 6
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 6
- 229940114124 ferulic acid Drugs 0.000 description 6
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 6
- HJBWJAPEBGSQPR-UHFFFAOYSA-N DMCA Natural products COC1=CC=C(C=CC(O)=O)C=C1OC HJBWJAPEBGSQPR-UHFFFAOYSA-N 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- 125000003118 aryl group Chemical group 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 4
- 238000006555 catalytic reaction Methods 0.000 description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- HJBWJAPEBGSQPR-GQCTYLIASA-N 3,4-dimethoxycinnamic acid Chemical compound COC1=CC=C(\C=C\C(O)=O)C=C1OC HJBWJAPEBGSQPR-GQCTYLIASA-N 0.000 description 3
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- MJKVTPMWOKAVMS-UHFFFAOYSA-N 3-hydroxy-1-benzopyran-2-one Chemical compound C1=CC=C2OC(=O)C(O)=CC2=C1 MJKVTPMWOKAVMS-UHFFFAOYSA-N 0.000 description 2
- NGSWKAQJJWESNS-ZZXKWVIFSA-M 4-Hydroxycinnamate Natural products OC1=CC=C(\C=C\C([O-])=O)C=C1 NGSWKAQJJWESNS-ZZXKWVIFSA-M 0.000 description 2
- DFYRUELUNQRZTB-UHFFFAOYSA-N Acetovanillone Natural products COC1=CC(C(C)=O)=CC=C1O DFYRUELUNQRZTB-UHFFFAOYSA-N 0.000 description 2
- 241000195940 Bryophyta Species 0.000 description 2
- WSNMPAVSZJSIMT-UHFFFAOYSA-N COc1c(C)c2COC(=O)c2c(O)c1CC(O)C1(C)CCC(=O)O1 Chemical compound COc1c(C)c2COC(=O)c2c(O)c1CC(O)C1(C)CCC(=O)O1 WSNMPAVSZJSIMT-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 239000002879 Lewis base Substances 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 2
- 208000000453 Skin Neoplasms Diseases 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 125000000490 cinnamyl group Chemical group C(C=CC1=CC=CC=C1)* 0.000 description 2
- 239000003974 emollient agent Substances 0.000 description 2
- 125000004185 ester group Chemical group 0.000 description 2
- 235000019439 ethyl acetate Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000008266 hair spray Substances 0.000 description 2
- 230000009931 harmful effect Effects 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 150000007527 lewis bases Chemical class 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 235000011929 mousse Nutrition 0.000 description 2
- AFDXODALSZRGIH-UHFFFAOYSA-N p-coumaric acid methyl ether Natural products COC1=CC=C(C=CC(O)=O)C=C1 AFDXODALSZRGIH-UHFFFAOYSA-N 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- 201000000849 skin cancer Diseases 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- WBYWAXJHAXSJNI-VOTSOKGWSA-M trans-cinnamate Chemical class [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 2
- HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 2
- SAJGCUXAHBJVRH-VFQQELCFSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;hydrate Chemical compound O.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO SAJGCUXAHBJVRH-VFQQELCFSA-N 0.000 description 1
- OGTNBMNOGUFLDI-UHFFFAOYSA-N (3-chloro-3,3-dimethoxyprop-1-enyl)benzene Chemical compound COC(Cl)(OC)C=CC1=CC=CC=C1 OGTNBMNOGUFLDI-UHFFFAOYSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- 229940093475 2-ethoxyethanol Drugs 0.000 description 1
- YIWUKEYIRIRTPP-UHFFFAOYSA-N 2-ethylhexan-1-ol Chemical compound CCCCC(CC)CO YIWUKEYIRIRTPP-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- XPPDIDRILNIYOL-UHFFFAOYSA-N 4-(3-chloroprop-1-enyl)-1,2-dimethoxybenzene Chemical compound COC1=CC=C(C=CCCl)C=C1OC XPPDIDRILNIYOL-UHFFFAOYSA-N 0.000 description 1
- DJHGAFSJWGLOIV-UHFFFAOYSA-N Arsenic acid Chemical compound O[As](O)(O)=O DJHGAFSJWGLOIV-UHFFFAOYSA-N 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- JEYCTXHKTXCGPB-UHFFFAOYSA-N Methaqualone Chemical compound CC1=CC=CC=C1N1C(=O)C2=CC=CC=C2N=C1C JEYCTXHKTXCGPB-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 229920000688 Poly[(2-ethyldimethylammonioethyl methacrylate ethyl sulfate)-co-(1-vinylpyrrolidone)] Polymers 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 239000011358 absorbing material Substances 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001335 aliphatic alkanes Chemical group 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 229940000488 arsenic acid Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000011095 buffer preparation Methods 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 229940114081 cinnamate Drugs 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical compound C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 150000001923 cyclic compounds Chemical class 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 150000003997 cyclic ketones Chemical class 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000004664 distearyldimethylammonium chloride (DHTDMAC) Substances 0.000 description 1
- 239000008387 emulsifying waxe Substances 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- SEBPBUWRSRLFQT-UHFFFAOYSA-N hydroperoxy(trihydroxy)silane Chemical compound OO[Si](O)(O)O SEBPBUWRSRLFQT-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000006317 isomerization reaction Methods 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 125000002950 monocyclic group Chemical group 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- NMRPBPVERJPACX-UHFFFAOYSA-N octan-3-ol Chemical compound CCCCCC(O)CC NMRPBPVERJPACX-UHFFFAOYSA-N 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000007142 ring opening reaction Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 231100000245 skin permeability Toxicity 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000037072 sun protection Effects 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 229910052714 tellurium Inorganic materials 0.000 description 1
- PORWMNRCUJJQNO-UHFFFAOYSA-N tellurium atom Chemical compound [Te] PORWMNRCUJJQNO-UHFFFAOYSA-N 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- LDHQCZJRKDOVOX-UHFFFAOYSA-N trans-crotonic acid Natural products CC=CC(O)=O LDHQCZJRKDOVOX-UHFFFAOYSA-N 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/12—Preparations containing hair conditioners
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/06—Preparations for styling the hair, e.g. by temporary shaping or colouring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/734—Ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/04—Oxygen-containing compounds
- C08K5/10—Esters; Ether-esters
- C08K5/101—Esters; Ether-esters of monocarboxylic acids
- C08K5/105—Esters; Ether-esters of monocarboxylic acids with phenols
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Polymers & Plastics (AREA)
- Medicinal Chemistry (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cosmetics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1. 式: (式中、 − R1およびR2は、同一でも異なっていてもよく、H、OH、NH2、CO2 H、またはOR6を示し、 − R4およびR5は、同一でも異なっていてもよく、H、OH、NH2、また はOR6を示し、 − R6は、直鎖または分岐のC1−C16アルキル、アルキレン、またはアルキ リン、または、置換または無置換のホモサイクリックまたはヘテロサイクリック 芳香族基を示し、 − R3は、R7と連結した、置換または無置換のホモサイクリックまたはヘテ ロサイクリック芳香環を示し、 - R7は、置換または無置換のホモサイクリックまたはヘテロサイクリック芳 香環、アルケン、またはR3に結合可能な官能基で置換されたアルカンを示す) で表わされる化合物およびその塩または付加物。 2. 1cm長のセル中で測定されたモル吸光値(molar absorbance value :m.a.v.)の最大吸光波長が1X104よりも長く、および/または、1 %重量/容量溶液において、少なくとも4X104Abs nmの全紫外線吸収度を 示す、請求項1に記載の化合物。 3. R3が、式: で表わされ、アルケン結合がシスまたはトランスのいずれかである、請求項1 または2に記載の化合物。 4. R3が、式: で表わされ、アルケン結合がシスまたはトランスのいずれかであり、CO2X が酸またはエステルのいずれかを示す、請求項1または2に記載の化合物。 5. R3が、式: で表わされる、請求項1または2に記載の化合物。 6. R3が、式: で表わされ、アルケン結合がシスまたはトランスのいずれかである、請求項1 または2に記載の化合物。 7. R3が、式: で表わされ、アルケン結合がシスまたはトランスのいずれかであり、CO2X が酸またはエステルのいずれかを示す、請求項1または2に記載の化合物。 8. R3が、式: で表わされる、請求項1または2に記載の化合物。 9. R1が、パラメトキシ基である、請求項1ないし8のいずれか1項 に記載の化合物。 10. R1が、OHを示し、R2が-OCH3を示す、請求項1ないし8の いずれか1項に記載の化合物。 11. CO2Xがエステルを示し、Xが、任意に炭素がヘテロ原子で置 換されてもよい、直鎖または分岐のC1−C16アルキル、アルケン、またはアル キレン、または、置換または無置換のホモサイクリックまたはヘテロサイクリッ ク環を示す、請求項4または7に記載の化合物。 12. CO2Xがエステル: を示す、請求項4または7に記載の化合物。 13. オリジナルの化合物の紫外線吸収スペクトルをシフトさせるpH 条件の変更を行った、請求項1ないし12のいずれか1項に記載の化合物を含有 する化合物。 14. pH条件の変更の結果、全紫外線吸収が増加する、請求項13に 記 載の化合物。 15. pH条件の変更の結果、さらなる最大波長が存在する、請求項1 3または14に記載の化合物。 16. さらなる最大波長が、紫外線吸収スペクトルのUVA領域に存在 する、請求項15に記載の化合物。 17. pH条件の変更が、塩基の添加によって引き起こされる、請求項 13ないし16のいずれか1項に記載の化合物。 18. カフェアート誘導体を含有する、請求項1ないし17のいずれか 1項に記載の化合物。 19. コウマラート誘導体を含有する、請求項1ないし17のいずれか 1項に記載の化合物。 20. 式: (式中、 − R1およびR2は、同一でも異なっていてもよく、H、OH、NH2、CO2 H、またはOR6を示し、 − R4およびR5は、同一でも異なっていてもよく、H、OH、NH2、また はOR6を示し、 − R6は、直鎖または分岐のC1−C16アルキル、アルキレン、またはアルキ リン、または、置換または無置換のホモサイクリックまたはヘテロサイクリック 芳香族基を示し、 − R3は、R7と連結した、芳香環を示し、 − R7は、ホモサイクリックまたはヘテロサイクリック芳香環、または無置 換の脂肪族基を示す) で表わされる化合物およびその塩または付加物。 21. 3,4−ジメトキシシンナミルクロリドのエステル化を含む、請 求項1ないし20のいずれか1項に記載の化合物の製造方法。 22. 4−メトキシシンナミルクロリドのエステル化を含む、請求項1 ないし20のいずれか1項に記載の化合物の製造方法。 23. 温血動物の髪または皮膚への紫外線ダメージを防止または減少さ せるために使用される、請求項1ないし20のいずれか1項に記載の化合物。 24. 温血動物の皮膚への紫外線ダメージを防止または減少させるため の医薬品の製造への、請求項1ないし20のいずれか1項に記載の化合物の用途 。 25. 請求項1ないし20のいずれか1項に記載の化合物を含有する組 成物を皮膚に適用することを含んでなる、皮膚保護の美容方法。 26. 請求項1ないし20のいずれか1項に記載の化合物を含有する組 成物を皮膚または髪に適用することを含んでなる、髪または皮膚のしわ防止また は減少の美容方法。 27. 請求項1ないし20のいずれか1項に記載の化合物およびアジュ バントを含有するサンスクリーン組成物。 28. 請求項1ないし20のいずれか1項に記載の化合物およびアジュ バントを含有する化粧品組成物。 29. 請求項1ないし20のいずれか1項に記載の化合物およびアジュ バントを含有する皮膚または髪に適用するための抗しわ組成物。 30. 請求項1ないし20のいずれか1項に記載の化合物およびアジュ バントを含有する皮膚または髪に適用するための組成物。 31. ヘアケア製品、ポリマー、インク、ペイント、、染料、着色剤か ら選択される組成物中への添加剤としての請求項1ないし20のいずれか1項に 記載の化合物の用途。 32. 化合物のpH条件を変えることを含んでなる、請求項1ないし1 2、 および、18ないし20のいずれか1項に記載の化合物の紫外線吸収スペクトル をシフトさせる方法。 33. pH条件の変更が塩基の添加によってもたらされる、請求項32 に記載の方法。
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9512855.9A GB9512855D0 (en) | 1995-06-23 | 1995-06-23 | Chemical compounds and methods of production thereof |
| GBGB9525162.5A GB9525162D0 (en) | 1995-12-08 | 1995-12-08 | Chemical compounds and methods of production thereof |
| GB9525162.5 | 1995-12-08 | ||
| GB9512855.9 | 1995-12-08 | ||
| PCT/GB1996/001481 WO1997000851A1 (en) | 1995-06-23 | 1996-06-21 | Chemical compounds and methods of production thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH11507941A true JPH11507941A (ja) | 1999-07-13 |
Family
ID=26307271
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9503670A Withdrawn JPH11507941A (ja) | 1995-06-23 | 1996-06-21 | 化学化合物およびその製造方法 |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0833812A1 (ja) |
| JP (1) | JPH11507941A (ja) |
| AU (1) | AU6132796A (ja) |
| WO (1) | WO1997000851A1 (ja) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004161774A (ja) * | 2002-11-14 | 2004-06-10 | Samsung Electronics Co Ltd | 耐光性を有する化合物及びこれを含むインク組成物 |
| WO2013002224A1 (ja) * | 2011-06-30 | 2013-01-03 | Dic株式会社 | 桂皮酸誘導体及びその重合体、ならびにその硬化物からなる液晶配向層 |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9715751D0 (en) | 1997-07-26 | 1997-10-01 | Ciba Geigy Ag | Formulations |
| AU4418997A (en) * | 1997-09-17 | 1999-04-05 | Procter & Gamble Company, The | Hair care compositions comprising hydroxycoumarins |
| BR9908870A (pt) * | 1998-03-16 | 2000-11-21 | Procter & Gamble | Processos para regularizarem a aparência da pele |
| KR100759240B1 (ko) * | 1999-06-18 | 2007-09-18 | 시바 스페셜티 케미칼스 홀딩 인크. | 미분된 유기 안료 혼합물을 포함하는 화장품 조성물 |
| DE19948117A1 (de) * | 1999-10-06 | 2001-04-12 | Basf Ag | Stabilisatorzusammensetzung |
| US6646153B1 (en) * | 2000-07-19 | 2003-11-11 | E. I. Du Pont De Nemours And Company | Hydroxyl functional urethanes having a tertiary carbamate bond |
| US20030045461A1 (en) | 2001-09-06 | 2003-03-06 | Jen-Chang Hsia | Composition and methods of esterified nitroxides gated with carboxylic acids |
| US7435438B1 (en) | 2003-05-16 | 2008-10-14 | Pure Bioscience | Disinfectant and method of use |
| CA2679955A1 (en) * | 2006-10-13 | 2008-05-29 | Reliance Life Sciences Pvt. Ltd. | Novel chemotherapeutic agents against inflammation and cancer |
| RU2010147447A (ru) | 2008-04-23 | 2012-05-27 | Басф Се (De) | Доставка гидрофобных полезных агентов из моющих средств для тела и подобных в ороговевший субстрат |
| EP2420548B1 (en) * | 2009-04-14 | 2018-07-04 | DIC Corporation | Liquid crystal composition containing polymerizable compound and liquid crystal display element using same |
| KR101918306B1 (ko) | 2010-09-14 | 2018-11-13 | 바스프 에스이 | Uv 흡수제로서의 특정한 비스(비페닐)트리아진 유도체 및 그의 혼합물의 용도 |
| WO2012052499A1 (en) | 2010-10-22 | 2012-04-26 | Basf Se | Use of silane and siloxane bis(biphenyl)triazine derivatives as uv absorbers |
| WO2013024099A1 (en) | 2011-08-16 | 2013-02-21 | Basf Se | Composition comprising active ingredient, oil and ionic liquid |
| EP2743337B1 (de) | 2012-12-14 | 2016-10-12 | Cognis IP Management GmbH | Oberflächenaktive polyglycerinderivate |
| JP6789822B6 (ja) | 2014-04-09 | 2020-12-16 | ビーエイエスエフ・ソシエタス・エウロパエアBasf Se | 化粧品製剤におけるuvフィルター用可溶化剤 |
| ES2832611T3 (es) | 2014-04-11 | 2021-06-10 | Basf Se | Mezclas de absorbentes de UV cosméticos |
| ES2785388T3 (es) | 2014-12-09 | 2020-10-06 | Basf Se | Agentes solubilizantes para filtros UV en formulaciones cosméticas |
| CN111057036B (zh) * | 2019-12-02 | 2021-10-08 | 五邑大学 | 一种香豆素衍生物及其制备方法与应用 |
| CN111202730B (zh) * | 2020-02-19 | 2021-03-23 | 五邑大学 | 一种香豆素衍生物在抑制酪氨酸酶活性中的应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4124724A (en) * | 1975-12-08 | 1978-11-07 | Agoro John W | Crystalline caffeic acid derivatives and compositions and method for treating snakebite |
| FR2612182B1 (fr) * | 1987-03-12 | 1989-06-23 | Centre Nat Rech Scient | Esters phenyliques substitues utilisables comme cristaux liquides ferroelectriques, leur preparation et leur utilisation dans un dispositif de visualisation electro-optique |
-
1996
- 1996-06-21 AU AU61327/96A patent/AU6132796A/en not_active Abandoned
- 1996-06-21 EP EP96918775A patent/EP0833812A1/en not_active Withdrawn
- 1996-06-21 JP JP9503670A patent/JPH11507941A/ja not_active Withdrawn
- 1996-06-21 WO PCT/GB1996/001481 patent/WO1997000851A1/en not_active Ceased
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004161774A (ja) * | 2002-11-14 | 2004-06-10 | Samsung Electronics Co Ltd | 耐光性を有する化合物及びこれを含むインク組成物 |
| WO2013002224A1 (ja) * | 2011-06-30 | 2013-01-03 | Dic株式会社 | 桂皮酸誘導体及びその重合体、ならびにその硬化物からなる液晶配向層 |
| JP5333685B2 (ja) * | 2011-06-30 | 2013-11-06 | Dic株式会社 | 化合物、ポリマー、液晶配向層、液晶表示素子及び光学異方体 |
| US9360708B2 (en) | 2011-06-30 | 2016-06-07 | Dic Corporation | Cinnamic acid derivative, polymer thereof, and liquid crystal alignment layer comprising cured product thereof |
| US10095066B2 (en) | 2011-06-30 | 2018-10-09 | Dic Corporation | Cinnamic acid derivative, polymer thereof, and liquid crystal alignment layer comprising cured product thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| AU6132796A (en) | 1997-01-22 |
| WO1997000851A1 (en) | 1997-01-09 |
| EP0833812A1 (en) | 1998-04-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH11507941A (ja) | 化学化合物およびその製造方法 | |
| US5518713A (en) | Benzoxazole derivatives, the use thereof as sunscreens and cosmetic compositions containing them | |
| US4387089A (en) | 4-(1,1-Dimethylethyl)-4'-methoxydibenzoylmethane | |
| JP3637055B2 (ja) | 光保護フィルターとしてのベンズイミダゾール誘導体の使用 | |
| CA1204779A (fr) | 3-benzylidene camphres, leur procede de preparation et leur utilisation pour la protection contre les rayons uv | |
| US4588839A (en) | Sulphonamides derived from 3-benzylidene-camphor and their application as UV filters | |
| AU738152B2 (en) | Indanylidene compounds, a process for their preparation and their use as UV absorbers | |
| US5000945A (en) | Method of stabilizing a UVB absorbing compound, a stabilized UV absorber, and a cosmetic composition containing the same | |
| GB2198945A (en) | Sunscreen cosmetic compositions containing 2-hydroxychalcone derivatives | |
| US5175340A (en) | New liposoluble unsaturated benzalmalonate derivatives and their use as absorbers for ultraviolet radiation in cosmetics | |
| IL186042A (en) | Benzoic acid ester compounds, their compositions, uses and associated methods | |
| US4797493A (en) | Benzylidene compounds | |
| US5565191A (en) | Cosmetic and dermatological compositions for the protection against UV radiation containing stilbene derivatives | |
| US5144081A (en) | Dialkoxybenzylidene-camphor derivatives | |
| US5004594A (en) | Benzylidenecamphor sulphonamides derived from amino acids and their application in cosmetics, particularly as sunscreens | |
| US5840282A (en) | Light screening compositions | |
| JPS61140543A (ja) | 4−メトキシ−2′−カルボキシジベンゾイルメタンおよびその塩 | |
| US5081308A (en) | Ultraviolet radiation absorbing compositions of bis-1,3-diketone derivatives of cyclohexane | |
| US5935563A (en) | Substituted benzylidenecyanoacetic acid esters | |
| JP2002053527A (ja) | 5,5−ジアリール−2,4−ペンタジエン酸エステル系化合物および該化合物を有効成分とする紫外線吸収剤 | |
| AU754785B2 (en) | Use of isoindolinone derivatives as stabilizers for organic materials | |
| JPH11514655A (ja) | 光安定性uv−a−フィルターを含有する化粧品製剤 | |
| EP0722714A2 (en) | Benzoxazole derivatives, the use thereof as sunscreens and cosmetic compositions containing them | |
| JP2780091B2 (ja) | 長波長紫外線吸収剤 | |
| AU1730699A (en) | Cosmetic and pharmaceutical preparations containing photostable UV filters |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080703 Year of fee payment: 10 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090703 Year of fee payment: 11 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090703 Year of fee payment: 11 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100703 Year of fee payment: 12 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100703 Year of fee payment: 12 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110703 Year of fee payment: 13 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110703 Year of fee payment: 13 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120703 Year of fee payment: 14 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120703 Year of fee payment: 14 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130703 Year of fee payment: 15 |
|
| LAPS | Cancellation because of no payment of annual fees |